Article

EMP3 as a prognostic biomarker correlates with EMT in GBM

2023-08-24

Abstract excerpt

<h4>Background: </h4> Glioblastoma (GBM) is the most aggressive malignant central nervous system tumor with a poor prognosis.The malignant transformation of glioma cells via epithelial-mesenchymal transition (EMT) has been observed as a main obstacle for glioblastoma treatment.Epithelial membrane protein 3 ( EMP3 ) is significantly associated with the malignancy of GBM and the prognosis of patients. Therefore, exp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0db0bf1e-4705-577a-84a6-7fcaeacdec68
DOI: 10.21203/rs.3.rs-3199536/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

EMP3 as a prognostic biomarker correlates with EMT in GBMDOI 10.21203/rs.3.rs-3199536/v1Read

Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axisSemantic proximity Read

Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of gliomaSemantic proximity Read

Identification of An Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature For Patients With GlioblastomaSemantic proximity Read

Integrated Analysis Identifies MEOX2 as a Malignant Driver and Prognostic Biomarker in Brain GliomaSemantic proximity Read

Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.Semantic proximity Read

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastomaSemantic proximity Read

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in GliomaSemantic proximity Read

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastomaSemantic proximity Read

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.Semantic proximity Read

Identification of Key Differentially Expressed Transcription Factors in GlioblastomaSemantic proximity Read

Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for GlioblastomaSemantic proximity Read

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in GlioblastomaSemantic proximity Read